PER 4.76% 10.0¢ percheron therapeutics limited

Ann: ATL1103 Higher Dose Study-ANP.AX, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,149 Posts.
    Point taken Sammy but to date they have spent in excess of 60 million to end up at this very point which is clearly unacceptable.
    Yes the results are fantastic and we have been saying for yonks that they have a drug in 1103 but yet to see any material progress in partnering since strong bridge handed it back because of funding issues.
    Is it all worth more than the current mc .... Yes
    Is the current Board formation imo the ones to take it forward ....No
    Last edited by kpkg: 11/10/16
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.